NeoGenomics (NASDAQ:NEO) shares plunged on Tuesday after the cancer lab operator reported lower-than-expected revenue for Q1 ...

AstraZeneca’s AZN first-quarter 2025 core earnings of $1.24 per American depositary share (ADS) beat the Zacks Consensus ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

Jay Sigel, who died from pancreatic cancer, was regarded as one of the best amateur golfers. He played in the Azalea ...

The case of an alleged victim of workplace harassment at the VA has dragged out for two years, and faces more yet delays. “My theme here is ‘justice delayed is justice denied’ – you learn that on Day ...

The Bushey community have raised £16k to support a family after their three-year-old’s brain cancer diagnosis “turned life upside down”.

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

Non-GAAP EPS guidance for 2025 was increased to a range of $6.70 to $7.00, up $0.15 at the midpoint from initial guidance. Total revenue reached $11.2 billion, with growth portfolio revenues ...

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial ...

Liz’s friends think it must be a joke or madness, but they aren’t saying it to her,” said a source in the know of Elizabeth ...

Quarterly net revenues of $155 million, up 12% year-over-year, with 4,268 active patients on therapy as of March 31, 2025 Results from Phase 3 PANOVA-3 trial in pancreatic cancer accepted as late-brea ...